The American Society for Clinical Oncology has included the findings of a trial co-led by Peter Mac investigators into a new treatment approach for head and neck cancers in its annual review of major advances against cancer.
Six Victorian Cancer Agency Research Fellowships have been awarded to Peter Mac early- and mid-career scientists, supporting research into key areas including the development of predictive biomarkers for therapy response and resistance, new cancer treatments and the integration of exercise into cancer care.
Peter Mac’s Prof Mark Dawson has been named the 2020 recipient of the McCulloch & Till Award from the International Society for Experimental Haematology – the first time an Australian has received the honour.
Dear Colleagues, Today we are excited to announce 16 speakers who will form part of the GAP 2020 conference program. With the final program to be announced in the New Year. Joining us from America and MD Anderson Cancer Centre: Patrick Hwu, MD Jeffrey E. Gershenwald, MD Kathleen M. Schmeler, MD...
Peter Mac scientists have found a way to target acute myeloid leukaemia (AML) at its source - a discovery that could yield a more effective treatment for this aggressive and often incurable blood cancer.
A study has confirmed the accuracy of iPrevent, an online tool developed at Peter Mac to help women understand and reduce their risk of breast cancer. The study of almost 16,000 women, published in JNCI Cancer Spectrum, found iPrevent gave accurate predictions of their breast cancer risk over a ten-year period.
The Peter MacCallum Cancer Centre acknowledges the traditional
owners of the land on which our five sites are located throughout Victoria.
We recognise their strength and resilience and pay our respects
to their Elders past and present.